CRH Completes LSE Delisting

NEW YORK--(BUSINESS WIRE)-- Further to the announcement made on March 13, 2026, CRH (NYSE: CRH) today confirms that the listings of its ordinary shares and its 7% preference shares on the official list of the UK Financial Conduct Authority, and the admission to trading of those shares on the main market for listed securities of the London Stock Exchange, have both been cancelled with effect from 08:00 a.m. (London) today, April 20, 2026.

CRH’s ordinary shares are now solely listed on the New York Stock Exchange.

Frequently Asked Questions and Shareholder Helpline

A FAQ document for shareholders holding ordinary shares is available at https://www.crh.com/investors/ordinary-shareholders/. A FAQ document for shareholders holding 7% preference shares is available at https://www.crh.com/investors/preference-shareholders/. A helpline is also available to assist shareholders, the contact details for which are included in the FAQ documents.

About CRH

CRH is the leading provider of building materials critical to modernizing infrastructure. With our team of 83,000 people across 4,000 locations, our unmatched scale, connected portfolio, and deep local relationships make us the partner of choice for transportation, water, and reindustrialization projects, shaping communities for a better tomorrow. CRH (NYSE: CRH) is a member of the S&P 500 Index. For more information, visit www.crh.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260420900289/en/

Tom Holmes
Head of Investor Relations
[email protected]

Lauren Schulz
Chief Communications Officer
[email protected]

Source: CRH

You May Also Be Interested In

• Cole Palmer Partners With Gopuff to Launch COLE’D, a New Line of Premium Ice, Including the World’s First Electrolyte Ice
• RETRANSMISSION: HIVE's Paraguay AI Infrastructure Performance Validated in Columbia University Study, Research Heads to NeurIPS
• Capitan Silver Receives Key Drill Permit for the Cruz De Plata Project and Commences Drilling on Untested High-Priority Regional Targets